Pharmafile Logo

Peter Impey

Exploring full potential of e-detailing data

Today’s high quality e-detailing data can create better quality conversations with healthcare professionals and result in improved access and relationships.

Anthill Agency

Novartis day

Novartis sales dip, but all eyes are on Entresto

Newheart failure drug could return the company to growth

Bristol-Myers Squibb (BMS) building

Opdivo gets EU lung cancer nod as kidney cancer trial is halted

Bristol-MyersSquibb's checkpoint inhibitor gains European license for lung cancer

EISAI

Eisai to transfer US manufacturing campus to Biogen

Willhand over Research Triangle Park facility incapacity-sharing deal

- PMLiVE

Sonia Ruiz Moran appointed president of EMVO

She joins the verification organisation from the General Pharmaceutical Council of Spain

- PMLiVE

Sharing knowledge to combat emerging threats

'One health' advocates say closer cooperation between human and animal medicine firms could offer new solution

- PMLiVE

The evolving biosimilars market

Safety and efficacy doubts remain a challenge

- PMLiVE

UK patients offered app to report adverse reactions

Yellow Card app allows potential side-effects tobe sent directly to the MHRA

- PMLiVE

TogoRun appoints Jonathan Kearney as a director

Healthcarecomms agency's London office also recruits Catherine Blaikley

- PMLiVE

AbbVie and C2N take tau antibody into clinic

Treatment being assessed for a progressive neurodegenerative disorder

- PMLiVE

Pharma must ‘create new social contract’

New task force established in UK to assess public’s view of the value and risk of medicines

- PMLiVE

Valeant buys Amoun Pharma for larger slice of MENA market

Comes after Canadian firm recently bought Salix for $11bn

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links